febit Receives European Union (EU) Patent for Synthesis of Minimal Genomes

LEXINGTON, Mass. (USA), and HEIDELBERG, Germany -– febit announced today the receipt of an EU patent, #EP 1 728 860B1, for its technology to synthesize minimal genomes. The new patent protects febit’s technology for combining genes to construct a minimal functional genome or parts of it. The EU patent complements earlier patents on the synthesis [...]

Five New Hospitals Order ValiMedTM MVS by CDEX to Protect Patients

TUCSON, AZ-- CDEX Inc. (OTCBB: CEXI) (www.cdexinc.com) announces it has received five orders for ValiMed™ Medication Validation Systems (MVS) from new hospital clients in states including Illinois, Pennsylvania, Florida, and Colorado. Studies worldwide continue to show high numbers of mistakes in the compounding of high-risk medications resulting in substantial harm to patients and economic loss [...]

Absorption Systems® Now Using the LTQ Orbitrap XL from Thermo Scientific

New technology enhances Absorption Systems’ metabolite identification capabilities EXTON, Pa.--Absorption Systems, a leader in testing drugs for ADMET (Absorption, Distribution, Metabolism, Excretion and Toxicity), announced today that the company has incorporated the LTQ Orbitrap XL Hybrid Fourier Transform mass spectrometer into its drug metabolism program. The introduction of the state-of-the-art technology enables more precise identification [...]

PerkinElmer Enters Into Agreement to Acquire Signature Genomic Laboratories, LLC

Acquisition brings new diagnostic services to global leader in pre-natal and newborn health screening WALTHAM, Mass.--PerkinElmer, Inc. (NYSE: PKI), a global leader focused on the health and safety of people and the environment, today announced that it has entered into a definitive agreement to acquire Signature Genomic Laboratories, LLC (Signature), a diagnostic genetic testing company [...]

Integrated DNA Technologies and Glycon Partner in Australia

CORALVILLE, Iowa and NEW SOUTH WALES, Australia -- Integrated DNA Technologies (IDT) and Glycon Pty Ltd of New South Wales, Australia, are partnering to bring IDT’s market leading products and services to researchers in Australia. IDT is among the world’s most respected manufacturers of custom synthetic oligonucleotides and genes. Glycon will offer Australia’s scientists local [...]

VisualSonics Announces Product Launch of VevoCQ(TM) Contrast Quantification Software

VevoCQ(TM) enables measurement of perfusion kinetics in tumors and other tissue TORONTO, April 14 -- VisualSonics Inc., the leader in real time, in vivo, high-resolution micro imaging systems, and Bracco Group, the foremost developer and manufacturer of ultrasound based contrast agents, today announced the launch of VevoCQ(TM) Advanced Quantification Software Tools for the Vevo(R) 2100 [...]

Digilab, Inc. is Pleased to Announce the Appointment of Santo J. Costa to its Board of Directors

Holliston, MA -- Digilab, Inc. is pleased to announce the appointment of Santo J. Costa to its Board of Directors. Mr. Costa is currently Of Counsel with Smith, Anderson, Blount, Dorsett, Mitchell & Jerrigan, L.L.P. of Raleigh, North Carolina, where he specializes in corporate law for life science companies. Mr. Costa is the former Vice [...]

Unilever Takes New Approach to Particle Sizing

Waxy semisolids, today the formulation vehicle for many pharmaceutical and personal care products, present a considerable challenge when it comes to particle size analysis, primarily because they are not liquid at ambient temperature. By taking a new approach to particle sizing for these materials using the Mastersizer 2000 system from Malvern Instruments, researchers at Unilever [...]

OxySense Releases Newest Product in GEN III Line of Optical Oxygen Monitoring Systems

OxySense, the Leader in Optical Oxygen Measurement and Permeation Systems for the Packaging Industries, is Bringing the Same Innovative Technology to Package Line Monitoring and Control DALLAS--OxySense®, Inc. announced today the release of its GEN III™ OxySentry System – the latest addition to the company’s GEN III line of optical oxygen monitoring and permeation systems. [...]

Micralyne Achieves ISO 13485 Certification to Better Serve BioMEMS and Microfluidic Device Manufacturers

Edmonton, AB -- Micralyne Inc., a world-renowned, independent MEMS solutions company, has been certified to ISO 13485, reinforcing Micralyne’s position as a leading enabler for medical companies requiring advanced BioMEMS and microfluidic devices. The certification complements Micralyne’s current ISO 9001:2008 certification and makes the company one of the only MEMS solution providers with the quality [...]

Access IBO on Knowledge Center